Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Brian A. Jonas, MD, PhD, FACP
Articles
Efficacy and Safety in CPX-351 vs 7+3 in Adults Younger Than 60 Years With AML-MRC or t-AML
Vera Pervitsky, PharmD, BCOP, BCPS;Ila M. Saunders, PharmD, BCOP, DipACLM, FHOPA;Mimi Lo, PharmD, BCOP, BCPS;Rebecca Young, PharmD, BCOP;Benjamin Moskoff, PharmD, BCOP;Yunyi Ren, MS;Machelle Wilson, PhD;Brian A. Jonas, MD, PhD, FACP;Marisela Banez, PharmD, BCOP, BCPS;Julie Guglielmo, PharmD, BCOP
August 7th 2025CPX-351 shows promise for younger adults with therapy-related AML, offering improved survival post-transplant despite lower initial remission rates.
Read More
Latest Updated Articles
Published: June 12th 2025 | Updated: June 16th 2025
Study: How Individual Carbohydrate Responses Reveal Metabolic Health and Potential Biomarkers
Published: June 10th 2025 | Updated: June 12th 2025
Department of Health and Human Services Reconstitutes ACIP, Removing 17 Sitting Members
Published: June 2nd 2025 | Updated: June 11th 2025
NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular Care
Published: June 3rd 2025 | Updated: June 11th 2025
ASCO 2025: Zongertinib Shows Strong Potential in HER2-Mutant NSCLC Treatment Landscape
Published: May 30th 2025 | Updated: June 5th 2025
Emerging Data: Impacts of ROCKstar and AGAVE-201
Published: April 18th 2025 | Updated: April 21st 2025
Measles Cases Climb to 800 in United States as Outbreak Spreads Across Borders
